Skip to main content
Earnings Labs
Oculis Holding AG logo

Oculis Holding AG (OCS)

NASDAQ·Healthcare·Biotechnology

$7.74

+2.80%

Mkt Cap $421.63M

Analyst Ratings

Buy

12

Hold

0

Sell

0

Price Target (13 analysts)

$36.75

Range $26.00 – $45.00

Implied Upside

+374.5%

Consensus $36.75 vs current $7.74